Posts
Endoscopy is a procedure that has been developed to assist in the removal of endometriosis from the human body. Endoscopy is also being used to help in the treatment of gallstones, cholecystitis, and gastric reflux disease among a number of other conditions. The recent developments in this industry have been driven by changes in government regulation and legislation. The increase in the number of malignancies and the introduction of fiscal policy in the region has resulted in political will on the part of the governments to strengthen public health services.
Rising product approval for endoscopy devices by regulatory
authorities is expected to drive growth of the global endoscopic stricture
management device market during the forecast period. For instance, in January
2020, Pentax Medical received the U.S. Food and Drug Administration (FDA)
approval for its Imagina Endoscopy System, which will be used in performing
gastrointestinal procedures, digital image enhancement system with Pentax
i-Scan. This endoscopy machine is equipped with an LED touch-screen interface,
which removes the need for periodic bulb replacement. Besides, it is far more
cost-efficient than the GI endoscopy system such as video endoscopy. Thus.
These factors are expected to drive growth of the global endoscopic
stricture management device market during the forecast period. Furthermore, increasing incidence of bleeding
during surgical procedures combined with growing number of endoscopic
procedures is expected to boost the global endoscopic stricture management
device market growth over the forecast period.
However, the lack of skilled healthcare professionals to perform
surgical procedures, especially in emerging economies combined with
complications related to endoscopic procedures such as bleeding and infection
is expected to hamper the global endoscopic stricture management device market
growth over the forecast period. Furthermore, among regions, North America is
expected to witness significant growth in the global endoscopic stricture
management device market during the forecast period. This is owing to
increasing prevalence of the gastrointestinal disease in the region. Moreover,
Europe is expected to register a robust growth rate over the forecast period.
This is owing to increasing number of surgical procedures in the region.
Key players operating in the global endoscopic structure
management device market are Boston Scientific Corporation, Becton, Dickinson
and Company, Cook Medical, Panmed Us, Olympus Corporation, Hobbs Medical, Inc.,
Medi-Globe Gmbh. Merit Medical Systems, Inc., and CONMED Corporation.
For instance, in October 2020, Olympus Corporation introduced
HANAROSTENT Esophagus TTS self-expanding metal stents (SEMS).
No comments:
Post a Comment